116 related articles for article (PubMed ID: 6376650)
1. From the National Institute of Allergy and Infectious Diseases. Summary of the 19th United States-Japan Joint Cholera Conference.
Edelman R; Pierce NF
J Infect Dis; 1984 Jun; 149(6):1014-7. PubMed ID: 6376650
[TBL] [Abstract][Full Text] [Related]
2. From the National Institute of Allergy and Infectious Diseases. Summary of the 21st United States-Japan Joint Cholera Conference.
Edelman R; Sack RB
J Infect Dis; 1986 Aug; 154(2):377-80. PubMed ID: 3722875
[No Abstract] [Full Text] [Related]
3. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
[TBL] [Abstract][Full Text] [Related]
4. Summary of the 27th United States-Japan Joint Conference on Cholera and Related Diarrheal Diseases.
Spriggs DR; Guerrant RL
J Infect Dis; 1993 Jan; 167(1):1-6. PubMed ID: 8093361
[No Abstract] [Full Text] [Related]
5. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
Kundu J; Mazumder R; Srivastava R; Srivastava BS
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
[TBL] [Abstract][Full Text] [Related]
6. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
Liao J; Gibson JA; Pickering BS; Watnick PI
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of recombinant Vibrio cholerae strains carrying heterologous genes encoding non-01 antigen or cholera enterotoxin.
Smirnova NI; Zhuravlyova EA; Livanova LF; Shopyreva SV
Microb Pathog; 1995 Aug; 19(2):65-72. PubMed ID: 8577236
[TBL] [Abstract][Full Text] [Related]
8. From the National Institute of Allergy and Infectious Diseases. Summary of the 25th United States-Japan Joint Conference on cholera and related diarrheal diseases.
Spriggs DR; Sack RB
J Infect Dis; 1990 Sep; 162(3):584-90. PubMed ID: 2201739
[No Abstract] [Full Text] [Related]
9. Cholera vaccines.
Ryan ET; Calderwood SB
Clin Infect Dis; 2000 Aug; 31(2):561-5. PubMed ID: 10987721
[TBL] [Abstract][Full Text] [Related]
10. Construction of an engineered bivalent vaccine strain consisting of Vibrio cholerae CT-B and LPS-O antigens.
Yu X; Ma Q
Chin J Biotechnol; 1994; 10(4):225-32. PubMed ID: 7780018
[TBL] [Abstract][Full Text] [Related]
11. Vibrio cholerae and cholera: out of the water and into the host.
Reidl J; Klose KE
FEMS Microbiol Rev; 2002 Jun; 26(2):125-39. PubMed ID: 12069878
[TBL] [Abstract][Full Text] [Related]
12. Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea.
Sánchez J; Holmgren J
Curr Opin Immunol; 2005 Aug; 17(4):388-98. PubMed ID: 15963708
[TBL] [Abstract][Full Text] [Related]
13. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
Stewart-Tull DE; Lucas C; Bleakley CR
Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
[TBL] [Abstract][Full Text] [Related]
14. Cholera toxin: genetic analysis, regulation, and role in pathogenesis.
Mekalanos JJ
Curr Top Microbiol Immunol; 1985; 118():97-118. PubMed ID: 3902383
[No Abstract] [Full Text] [Related]
15. Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.
Herrington DA; Hall RH; Losonsky G; Mekalanos JJ; Taylor RK; Levine MM
J Exp Med; 1988 Oct; 168(4):1487-92. PubMed ID: 2902187
[TBL] [Abstract][Full Text] [Related]
16. Expression of Vibrio cholerae virulence genes in response to environmental signals.
Peterson KM
Curr Issues Intest Microbiol; 2002 Sep; 3(2):29-38. PubMed ID: 12400636
[TBL] [Abstract][Full Text] [Related]
17. Summary of the 22nd United States-Japan Joint Cholera Conference.
Edelman R; Sack RB; Ohtomo N
J Infect Dis; 1987 Jun; 155(6):1352-6. PubMed ID: 3572049
[No Abstract] [Full Text] [Related]
18. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
[TBL] [Abstract][Full Text] [Related]
20. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
